277 related articles for article (PubMed ID: 29128617)
21. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges.
Ramazani F; Chen W; van Nostrum CF; Storm G; Kiessling F; Lammers T; Hennink WE; Kok RJ
Int J Pharm; 2016 Feb; 499(1-2):358-367. PubMed ID: 26795193
[TBL] [Abstract][Full Text] [Related]
22. New strategies for the microencapsulation of tetanus vaccine.
Schwendeman SP; Tobío M; Joworowicz M; Alonso MJ; Langer R
J Microencapsul; 1998; 15(3):299-318. PubMed ID: 9608394
[TBL] [Abstract][Full Text] [Related]
23. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system.
Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK
J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022
[TBL] [Abstract][Full Text] [Related]
24. Emulsion-templated liquid core-polymer shell microcapsule formation.
Ao Z; Yang Z; Wang J; Zhang G; Ngai T
Langmuir; 2009 Mar; 25(5):2572-4. PubMed ID: 19437681
[TBL] [Abstract][Full Text] [Related]
25. Improved double emulsion technology for fabricating autofluorescent microcapsules as novel ultrasonic/fluorescent dual-modality contrast agents.
Gong A; Ma X; Xiang L; Ren W; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2014 Apr; 116():561-7. PubMed ID: 24583258
[TBL] [Abstract][Full Text] [Related]
26. Preparation and properties of nanosized biodegradable polymer capsules.
Sakai H; Sekita A; Tanaka K; Sakai K; Kondo T; Abe M
J Oleo Sci; 2011; 60(11):569-73. PubMed ID: 22027022
[TBL] [Abstract][Full Text] [Related]
27. Facile fabrication of biocompatible PLGA drug-carrying microspheres by O/W pickering emulsions.
Wei Z; Wang C; Liu H; Zou S; Tong Z
Colloids Surf B Biointerfaces; 2012 Mar; 91():97-105. PubMed ID: 22088755
[TBL] [Abstract][Full Text] [Related]
28. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis.
Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425
[TBL] [Abstract][Full Text] [Related]
29. Preparation of PLGA microparticles by an emulsion-extraction process using glycofurol as polymer solvent.
Aubert-Pouëssel A; Venier-Julienne MC; Saulnier P; Sergent M; Benoît JP
Pharm Res; 2004 Dec; 21(12):2384-91. PubMed ID: 15648273
[TBL] [Abstract][Full Text] [Related]
30. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
[TBL] [Abstract][Full Text] [Related]
31. Monodisperse liquid-filled biodegradable microcapsules.
Berkland C; Pollauf E; Varde N; Pack DW; Kim KK
Pharm Res; 2007 May; 24(5):1007-13. PubMed ID: 17372691
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
[TBL] [Abstract][Full Text] [Related]
33. Poly (lactic-co-glycolic acid) particles prepared by microfluidics and conventional methods. Modulated particle size and rheology.
Perez A; Hernández R; Velasco D; Voicu D; Mijangos C
J Colloid Interface Sci; 2015 Mar; 441():90-7. PubMed ID: 25490568
[TBL] [Abstract][Full Text] [Related]
34. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification.
Lamprecht A; Ubrich N; Hombreiro Pérez M; Lehr C; Hoffman M; Maincent P
Int J Pharm; 1999 Jul; 184(1):97-105. PubMed ID: 10425355
[TBL] [Abstract][Full Text] [Related]
35. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
36. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
[TBL] [Abstract][Full Text] [Related]
37. pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin.
Sun S; Liang N; Yamamoto H; Kawashima Y; Cui F; Yan P
Int J Nanomedicine; 2015; 10():3489-98. PubMed ID: 25999713
[TBL] [Abstract][Full Text] [Related]
38. [Research on preparation and quality control of drug-carried poly lactic-co-glycolic acid microbubble].
Li Q; Quan X; Wang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1051-5. PubMed ID: 21089669
[TBL] [Abstract][Full Text] [Related]
39. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A
Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
